USFDA completes unannounced inspection at Caplin Point’s arm’s manufacturing facility in Tamil Nadu

10 Aug 2024 Evaluate

The United States Food and Drug Administration (USFDA) has completed an unannounced inspection at Caplin Point Laboratories’ Subsidiary, Caplin Steriles’ injectable and ophthalmic manufacturing facility located at Gummidipoondi in the Indian state of Tamil Nadu.   

The inspection was conducted between August 5, 2024 and August 9, 2024 and concluded with zero observations. This outcome underscores the company’s strong commitment to maintaining the highest standards of integrity, quality, safety, and regulatory compliance in its operations. 

Caplin Point Laboratories is engaged mainly in manufacturing a wide range of Ointments, Creams and other External application preparations in addition to the regular segments of pharmaceutical formulations.


Caplin Point Lab Share Price

1918.15 -50.20 (-2.55%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×